FDA, CDC Halt Use of Chikungunya Vaccine in Adults 60+ After Two Deaths Reported

On May 9, 2025, the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) recommended a temporary pause in the use of Ixchiq, a live virus vaccine designed to prevent chikungunya virus infection, in adults aged 60 years and older. The recommendation follows reports of serious post-marketing adverse […]
CDC Says All Children Traveling Abroad Need Extra MMR Shot to Prevent Measles in U.S.

After 16 cases of measles were reported in the U.S. linked to international travel, the U.S. Centers for Disease Control and Prevention (CDC) issued a health alert on June 21, 2023, recommending that all eligible infants aged six months or older get an extra measles vaccine before traveling abroad this summer. Despite being licensed by […]
Vaccine Market Valued at $93 Billion by 2026

A recent report by Fortune Business Insights projects the value of the world market for vaccines to reach $93.08 billion by 2026, with a Compound Annual Growth Rate (CAGR) of 10.7 percent during the forecast period.1 One of the main drivers of the vaccine market is the need for greater supplies of vaccines, given stricter government […]